Pharma Pulse 11/25/24: Pharma Stilll Struggling with Digital Transformation, Removing Barriers to Gene Therapies & more

Survey Suggests Pharma Industry Still Struggling with Digital Transformation

The pharma industry is actively embracing new technologies like machine learning and AI, but new data suggests that the adoption is being hindered.1 Aside from these new technologies, the pharma industry is still facing hurdles in general digital transformation.

Potential Solutions to Remove Barriers to Gene Therapies

Like many novel therapies, gene therapies are not without challenges that can be solved through a combination of policy and market changes. In order to improve patient access to these life-saving therapies new payment solutions, education efforts around the availability of these treatments and their benefits and risks, and the use of appropriate value assessment methods are all needed, according to a white paper from the National Pharmaceutical Council (NPC).

Novartis Lifts Outlook, Citing Cancer and Inflammatory Drugs

Novartis AG raised its medium-term sales target, citing upbeat expectations for new cancer and immunological disease medicines, as well as treatments for neurological and cardiovascular conditions.

Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape

Novotech has published an in-depth whitepaper titled "Vaccines – Global Clinical Trial Landscape (2024)." This report provides a comprehensive analysis of the evolving vaccine development landscape, offering strategic insights for biotech and pharma stakeholders.

Nicholas Saraceno on LinkedIn

So we at Pharmaceutical Commerce Magazine did a thing. We welcome a new LinkedIn newsletter, Supply Chain Solutions. It's intended to provide fresh content based on sustaining the flow of products, information, and funds. This will be delivered via the latest news items, video content, and podcast episodes. Be sure to stay in the loop by subscribing and following - volume I is below!

https://lnkd.in/gp_ZxkQR

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs